Global Life Sciences Software Market Forecast By Top Leading Players: Dassault Systèmes, LabVantage

BRUSSELS - Dec. 4, 2022 - PRLog -- The market for life sciences software (such as eTMF, LIMS, computer-aided drug discovery, RWE, ERP, CRM, QMS, virtual trials, patient recruitment software, patient & outcomes data management, etc.) is driven by rising R&D spend and pipeline, expanding number and size of biotechs, Covid-accelerated decentralized trials, increasing cost efficiencies and shorter time to market.

The Life Sciences Software market growth is being fueled by increased R&D efforts around the globe, stringent regulatory compliance/reporting, increasing use of AI & ML during the drug discovery and clinical trial phases, and growing demand for novel software solutions especially designed for biologics/cell, and gene therapy.

Drug Discovery Software Likely to Witness Fastest Growth
The rising pressure on pharma and biotech companies to lower costs during the research and preclinical stages of drug development, reduce timelines, and increase transparency through the use of deep learning software tools has resulted in a niche market for drug discovery software that is expanding quickly.

"Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge." - Executive, Leading Software Provider, US

Explore Premium Report on Life Sciences Software Market @ https://meditechinsights.com/life-sciences-software-market/

Mounting Interest in Novel Software Solutions Specifically Designed for Biologics
With quickly growing research on advanced therapies such as cell and gene therapies and personalized vaccines, there is robust demand for software solutions to maximize process and workflow efficiencies across services. The FDA predicts that by 2025, 10 to 20 cell and gene therapy products will be approved a year. Companies are entering or growing into the biologics software space to take advantage of growth opportunities. Some of the key technology providers for CGT include Vineti, TrakCel, Be The Match, SAP, WellSky, Synthace and Cytiva.

Competitive Landscape Analysis of Life Sciences Software Market
The global life sciences software market is highly competitive and fragmented. Some of the key players include Dassault Systèmes, LabVantage, PerkinElmer, Schrodinger, ICON, Veeva, PhlexGlobal, Saama, IQVIA, Parexel, Signant Health, Abbott, Science37, Medidata, IBM, Koneksa, SAP, Oracle, Optibrium, and Instem.